Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase - PubMed (original) (raw)

Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase

O Thastrup et al. Proc Natl Acad Sci U S A. 1990 Apr.

Abstract

Thapsigargin, a tumor-promoting sesquiterpene lactone, discharges intracellular Ca2+ in rat hepatocytes, as it does in many vertebrate cell types. It appears to act intracellularly, as incubation of isolated rat liver microsomes with thapsigargin induces a rapid, dose-dependent release of stored Ca2+. The thapsigargin-releasable pool of microsomal Ca2+ includes the pools sensitive to inositol 1,4,5-trisphosphate and GTP. Thapsigargin pretreatment of microsomes blocks subsequent loading with 45Ca2+, suggesting that its target is the ATP-dependent Ca2+ pump of endoplasmic reticulum. This hypothesis is strongly supported by the demonstration that thapsigargin causes a rapid inhibition of the Ca2(+)-activated ATPase activity of rat liver microsomes, with an identical dose dependence to that seen in whole cell or isolated microsome Ca2+ discharge. The inhibition of the endoplasmic reticulum isoform of the Ca2(+)-ATPase is highly selective, as thapsigargin has little or no effect on the Ca2(+)-ATPases of hepatocyte or erythrocyte plasma membrane or of cardiac or skeletal muscle sarcoplasmic reticulum. These results suggest that thapsigargin increases the concentration of cytosolic free Ca2+ in sensitive cells by an acute and highly specific arrest of the endoplasmic reticulum Ca2+ pump, followed by a rapid Ca2+ leak from at least two pharmacologically distinct Ca2+ stores. The implications of this mechanism of action for the application of thapsigargin in the analysis of Ca2+ homeostasis and possible forms of Ca2+ control are discussed.

PubMed Disclaimer

Cited by

Ca²⁺-sensor proteins in the autophagic and endocytic traffic.
Ghislat G, Knecht E. Ghislat G, et al. Curr Protein Pept Sci. 2013 Mar;14(2):97-110. doi: 10.2174/13892037112139990033. Curr Protein Pept Sci. 2013. PMID: 23305313 Free PMC article. Review.
From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development.
Christensen SB, Simonsen HT, Engedal N, Nissen P, Møller JV, Denmeade SR, Isaacs JT. Christensen SB, et al. Prog Chem Org Nat Prod. 2021;115:59-114. doi: 10.1007/978-3-030-64853-4_2. Prog Chem Org Nat Prod. 2021. PMID: 33797641
Calcium transfer from the ER to other organelles for optimal signaling in Toxoplasma gondii.
Li ZH, Asady B, Chang L, Triana MAH, Li C, Coppens I, Moreno SNJ. Li ZH, et al. bioRxiv [Preprint]. 2024 Dec 5:2024.08.15.608087. doi: 10.1101/2024.08.15.608087. bioRxiv. 2024. PMID: 39185237 Free PMC article. Preprint.
Gene Expression Profile of the Human Colorectal Carcinoma LoVo Cells Treated With Sporamin and Thapsigargin.
Yang C, Chen SJ, Chen BW, Zhang KW, Zhang JJ, Xiao R, Li PG. Yang C, et al. Front Oncol. 2021 May 25;11:621462. doi: 10.3389/fonc.2021.621462. eCollection 2021. Front Oncol. 2021. PMID: 34113558 Free PMC article.
Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes.
Kao E, Shinohara M, Feng M, Lau MY, Ji C. Kao E, et al. Hepatology. 2012 Aug;56(2):594-604. doi: 10.1002/hep.25702. Epub 2012 Jun 11. Hepatology. 2012. PMID: 22407670 Free PMC article.

References

1. Biochem Biophys Res Commun. 1984 May 16;120(3):858-64 - PubMed
1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
1. J Biol Chem. 1985 Mar 25;260(6):3440-50 - PubMed
1. FEBS Lett. 1985 Jun 3;185(1):147-50 - PubMed
1. Br J Pharmacol. 1985 Jul;85(3):705-12 - PubMed

Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase - PubMed (original) (raw)